Somerville Kurt F Edwards Lifesciences Corp Transaction History

Somerville Kurt F

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$61.71 - $77.76 $1.45 Million - $1.83 Million	-23,525 Reduced 83.64%	4,600 $350,000
Q3 2023 Nov 13, 2023	BUY	$69.28 - $93.38 $302,753 - $408,070	4,370 Added 18.4%	28,125 $1.95 Million
Q2 2023 Aug 11, 2023	BUY	$81.41 - $94.33 $122,522 - $141,966	1,505 Added 6.76%	23,755 $2.24 Million
Q1 2023 May 10, 2023	BUY	$74.26 - $84.51 $666,483 - $758,477	8,975 Added 67.61%	22,250 $1.84 Million
Q4 2022 Feb 09, 2023	SELL	$68.3 - $87.44 $988,984 - $1.27 Million	-14,480 Reduced 52.17%	13,275 $990,000
Q3 2022 Nov 08, 2022	BUY	$82.37 - $107.29 $280,469 - $365,322	3,405 Added 13.98%	27,755 $2.29 Million
Q2 2022 Jul 19, 2022	BUY	$86.5 - $128.27 $705,234 - $1.05 Million	8,153 Added 50.34%	24,350 $2.32 Million
Q1 2022 May 17, 2022	BUY	$101.96 - $128.34 $416,506 - $524,268	4,085 Added 33.73%	16,197 $1.91 Million
Q4 2021 Feb 08, 2022	BUY	$106.37 - $130.68 $936,268 - $1.15 Million	8,802 Added 265.92%	12,112 $1.57 Million
Q3 2021 Nov 10, 2021	BUY	$102.91 - $122.75 $340,632 - $406,302	3,310 New	3,310 $375,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Somerville Kurt F, based on Form 13F filings with the SEC.

Stay updated on Somerville Kurt F with notifications on news.